134 related articles for article (PubMed ID: 23784717)
1. Fluorescent THF-based fructose analogue exhibits fructose-dependent uptake.
Tanasova M; Plutschack M; Muroski ME; Sturla SJ; Strouse GF; McQuade DT
Chembiochem; 2013 Jul; 14(10):1263-70. PubMed ID: 23784717
[TBL] [Abstract][Full Text] [Related]
2. New fluorinated fructose analogs as selective probes of the hexose transporter protein GLUT5.
Soueidan OM; Trayner BJ; Grant TN; Henderson JR; Wuest F; West FG; Cheeseman CI
Org Biomol Chem; 2015 Jun; 13(23):6511-21. PubMed ID: 25975431
[TBL] [Abstract][Full Text] [Related]
3. Development of high-affinity ligands and photoaffinity labels for the D-fructose transporter GLUT5.
Yang J; Dowden J; Tatibouët A; Hatanaka Y; Holman GD
Biochem J; 2002 Oct; 367(Pt 2):533-9. PubMed ID: 12119043
[TBL] [Abstract][Full Text] [Related]
4. Radiopharmacological evaluation of 6-deoxy-6-[18F]fluoro-D-fructose as a radiotracer for PET imaging of GLUT5 in breast cancer.
Wuest M; Trayner BJ; Grant TN; Jans HS; Mercer JR; Murray D; West FG; McEwan AJ; Wuest F; Cheeseman CI
Nucl Med Biol; 2011 May; 38(4):461-75. PubMed ID: 21531283
[TBL] [Abstract][Full Text] [Related]
5. Expression and function of hexose transporters GLUT1, GLUT2, and GLUT5 in breast cancer-effects of hypoxia.
Hamann I; Krys D; Glubrecht D; Bouvet V; Marshall A; Vos L; Mackey JR; Wuest M; Wuest F
FASEB J; 2018 Sep; 32(9):5104-5118. PubMed ID: 29913554
[TBL] [Abstract][Full Text] [Related]
6. Fluorescent fructose derivatives for imaging breast cancer cells.
Levi J; Cheng Z; Gheysens O; Patel M; Chan CT; Wang Y; Namavari M; Gambhir SS
Bioconjug Chem; 2007; 18(3):628-34. PubMed ID: 17444608
[TBL] [Abstract][Full Text] [Related]
7. Fructose-coated nanoparticles: a promising drug nanocarrier for triple-negative breast cancer therapy.
Zhao J; Babiuch K; Lu H; Dag A; Gottschaldt M; Stenzel MH
Chem Commun (Camb); 2014 Dec; 50(100):15928-31. PubMed ID: 25382088
[TBL] [Abstract][Full Text] [Related]
8. Intestinal fructose transport and malabsorption in humans.
Jones HF; Butler RN; Brooks DA
Am J Physiol Gastrointest Liver Physiol; 2011 Feb; 300(2):G202-6. PubMed ID: 21148401
[TBL] [Abstract][Full Text] [Related]
9. Simple-sugar meals target GLUT2 at enterocyte apical membranes to improve sugar absorption: a study in GLUT2-null mice.
Gouyon F; Caillaud L; Carriere V; Klein C; Dalet V; Citadelle D; Kellett GL; Thorens B; Leturque A; Brot-Laroche E
J Physiol; 2003 Nov; 552(Pt 3):823-32. PubMed ID: 12937289
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a specific inhibitor of human GLUT5 by virtual screening and in vitro transport evaluation.
George Thompson AM; Ursu O; Babkin P; Iancu CV; Whang A; Oprea TI; Choe JY
Sci Rep; 2016 Apr; 6():24240. PubMed ID: 27074918
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and characterization of 6-deoxy-6-fluoro-D-fructose as a potential compound for imaging breast cancer with PET.
Trayner BJ; Grant TN; West FG; Cheeseman CI
Bioorg Med Chem; 2009 Aug; 17(15):5488-95. PubMed ID: 19586773
[TBL] [Abstract][Full Text] [Related]
12. An essential role for GLUT5-mediated fructose utilization in exacerbating the malignancy of clear cell renal cell carcinoma.
Jin X; Liang Y; Liu D; Luo Q; Cai L; Wu J; Jia L; Chen WL
Cell Biol Toxicol; 2019 Oct; 35(5):471-483. PubMed ID: 31102011
[TBL] [Abstract][Full Text] [Related]
13. Targeting of GLUT5 for Transporter-Mediated Drug-Delivery Is Contingent upon Substrate Hydrophilicity.
Nahrjou N; Ghosh A; Tanasova M
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34064801
[TBL] [Abstract][Full Text] [Related]
14. Passive fructose transporters in disease: a molecular overview of their structural specificity.
McQuade DT; Plutschack MB; Seeberger PH
Org Biomol Chem; 2013 Aug; 11(30):4909-20. PubMed ID: 23784005
[TBL] [Abstract][Full Text] [Related]
15. Tunable GLUT-Hexose Binding and Transport via Modulation of Hexose C-3 Hydrogen-Bonding Capabilities.
Kumar Kondapi VP; Soueidan OM; Cheeseman CI; West FG
Chemistry; 2017 Jun; 23(33):8073-8081. PubMed ID: 28346703
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of fructose analogues as inhibitors of the D-fructose transporter GLUT5.
Tatibouët A; Yang J; Morin C; Holman GD
Bioorg Med Chem; 2000 Jul; 8(7):1825-33. PubMed ID: 10976531
[TBL] [Abstract][Full Text] [Related]
17. Diet-induced epigenetic regulation in vivo of the intestinal fructose transporter Glut5 during development of rat small intestine.
Suzuki T; Douard V; Mochizuki K; Goda T; Ferraris RP
Biochem J; 2011 Apr; 435(1):43-53. PubMed ID: 21222652
[TBL] [Abstract][Full Text] [Related]
18. Fructose uptake in rat adipocytes: GLUT5 expression and the effects of streptozotocin-induced diabetes.
Hajduch E; Darakhshan F; Hundal HS
Diabetologia; 1998 Jul; 41(7):821-8. PubMed ID: 9686924
[TBL] [Abstract][Full Text] [Related]
19. d-Fructose Modification Enhanced Internalization of Mixed Micelles in Breast Cancer Cells via GLUT5 Transporters.
Zhou X; Qin X; Gong T; Zhang ZR; Fu Y
Macromol Biosci; 2017 Jul; 17(7):. PubMed ID: 28346751
[TBL] [Abstract][Full Text] [Related]
20. Transepithelial transports of rare sugar D-psicose in human intestine.
Hishiike T; Ogawa M; Hayakawa S; Nakajima D; O'Charoen S; Ooshima H; Sun Y
J Agric Food Chem; 2013 Jul; 61(30):7381-6. PubMed ID: 23844903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
